Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
Status:
Completed
Trial end date:
1998-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Dimethylxanthenone acetic acid may stop the growth of cancer cells by stopping
blood flow to the tumor.
PURPOSE: Phase I trial to study the effectiveness of dimethylxanthenone acetic acid in
treating patients with solid tumors that have not responded to previous therapy.